Tppl Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
as on 17-06-2024
- Paid Up Capital ₹ 0.15 M
as on 17-06-2024
- Company Age 13 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.26 M
as on 17-06-2024
- Revenue 0.78%
(FY 2023)
- Profit -25.68%
(FY 2023)
- Ebitda -6.09%
(FY 2023)
- Net Worth 7.73%
(FY 2023)
- Total Assets 1.35%
(FY 2023)
About Tppl Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹7.26 M.
Rishi Bhatia, Vivek Bansal, and Manohar Chhabra serve as directors at the Company.
- CIN/LLPIN
U24232RJ2011PTC037198
- Company No.
037198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tppl Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishi Bhatia  | Director | 01-Dec-2011 | Current |
| Vivek Bansal | Director | 24-Dec-2015 | Current |
| Manohar Chhabra | Director | 11-May-2012 | Current |
Financial Performance of Tppl Pharmaceuticals.
Tppl Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.78% increase. The company also saw a substantial fall in profitability, with a 25.68% decrease in profit. The company's net worth moved up by a moderate rise of 7.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tppl Pharmaceuticals?
In 2023, Tppl Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Nov 2022 | ₹1.91 M | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2020 | ₹1.75 M | Open |
Others Creation Date: 20 Sep 2016 | ₹3.60 M | Open |
How Many Employees Work at Tppl Pharmaceuticals?
Tppl Pharmaceuticals has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tppl Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tppl Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
